This announcement is a separate document:
東和薬品：2025年3月期 第2四半期（中間期）決算補足説明資料
TOWA Pharmaceutical: Supplementary explanation of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated